Bioequivalence Study of Different Aprocitentan Tablet Formulations

Clinical trial NCT05196399 · COMPLETED

Trial details

NCT number: NCT05196399
Sponsor: Idorsia Pharmaceuticals Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2022-02-02
Primary completion: 2022-03-27
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.